Clinical trial

Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy…

NCT00193895 · Trans Tasman Radiation Oncology Group, Other · Completed

Key facts

NCT number NCT00193895
Title Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck
Official title Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
Lead sponsor Trans Tasman Radiation Oncology Group, Other
Collaborators Princess Alexandra Hospital, Brisbane, Australia The Royal Australian and New Zealand College of Radiologists
Status Completed
Phase Phase 3
Study type Interventional
Conditions Skin Cancer
Intervention type Drug, Radiation
Interventions Carboplatin, Radiotherapy
Enrollment 321
Start date Apr 1, 2005
Primary completion Mar 1, 2016
Completion Mar 31, 2016
First posted Sep 19, 2005
Last update posted Apr 6, 2018
Countries Australia, New Zealand

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies